Clinical trial Recruiting at 1 site Interventional

Comparing higher and standard doses of zinc for very preterm infants

Official title: Higher and Standard Doses of Enteral Zinc Supplementation in Very Preterm Infants: A Randomized Controlled Trial

Run by Prince of Songkla University · NCT06219525 · Data updated 2026-11-12

This study tests if giving very preterm infants a higher dose of zinc can help them grow better and develop more normally compared to a standard dose.

More Zinc Deficiency trials

Quick facts

Study typeInterventional
SexAll
Enrollment120 (estimated)
SponsorPrince of Songkla University
Academic / other
Locations1 site (Hat Yai, Changwat Songkhla)
StatusRecruiting
StartedApril 2, 2024
Main results expectedDecember 31, 2025
Study endsDecember 31, 2027
Registry record updatedSeptember 19, 2024
Trial IDNCT06219525 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are very preterm neonates born between 24 and 32 weeks of gestation with a body weight less than 800 grams.

Probably not a fit

Patients who may not benefit from this study include those with congenital infections, severe birth asphyxia, or other significant health complications.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effects of higher (10 mg/day) versus standard (1 mg/day) doses of zinc supplementation in very preterm infants with a birth weight of less than 1800 grams. The study involves random allocation of neonates to receive either dose, with the administration of zinc occurring once daily after feeding. The primary outcomes include growth velocities and neurodevelopmental assessments at 24 months postnatal age. The trial is conducted in a blinded manner to ensure unbiased results.

Why it matters

Potential benefit: If successful, this study could improve growth and neurodevelopment outcomes in very preterm infants suffering from zinc deficiency.

How similar studies have gone: Other studies have shown promising results with zinc supplementation in preterm infants, indicating potential benefits in growth and development.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Very preterm neonates (gestational age \[GA\]: 24 0/7-32 6/7 weeks and BW: 401-1800 grams) were consecutively admitted in the NICU and NMCU
* Body weight at enrollment less than 800 grams
* Stable neonates and full enteral feeding (150 mL/kg/day) at least for a few days

Exclusion Criteria:

* Outborn neonate who was admitted in study center after 7 days of life
* Congenital infections
* Malformations, syndromes, or genetic defects
* Evidence of culture proven sepsis or necrotizing enterocolitis or death diagnosed before enrollment
* Gastrointestinal (GI) surgery or high GI fluid output (usually ileostomy losses)
* Unstable neonate during weighing including on intercostal drainage tube or drainage
* Neonates need diuretics more than 7 days
* Severe birth asphyxia (5-minute Apgar score less than 4)
* Parents' decision not to participate the study

Where it's running

  • Songklanagarind Hospital, Prince of Songkla University
    Hat Yai, Changwat Songkhla, Thailand
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.